Review



quantikine elisa human fibronectin immunoassay  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    R&D Systems quantikine elisa human fibronectin immunoassay
    Quantikine Elisa Human Fibronectin Immunoassay, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 22 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/quantikine+elisa+human+fibronectin+immunoassay/Human+Fibronectin+Quantikine+ELISA+Kit/pm41365401-320-6-12
    Average 94 stars, based on 22 article reviews
    quantikine elisa human fibronectin immunoassay - by Bioz Stars, 2026-10
    94/100 stars

    Images

    Related Articles

    Enzyme-linked Immunosorbent Assay:

    Article Title: Liver-derived, circulating plasma fibronectin regulates trabecular bone mass and bone formation in adult male mice and its levels in sera associates with bone density in aging men.
    Article Snippet: Please cite this article as: Mahdokht Mahmoodi , Claudie Berger , Mir-Hamed Nabavi , Yongjun Xiao , Lucie Canaff , Monica Pata , Jingjing Li , Mathieu Ferron , Monzur Murshed , David Goltzman , Suzanne N. Morin , Mari T. Kaartinen , Liver-derived, circulating plasma fibronectin regulates trabecular bone mass and bone formation in adult male mice and its levels in sera associates with bone density in aging men, Matrix Biology (2025), doi: https://doi.org/10.1016/j.matbio.2025.12.001

    Article Title: Electric currents of 448 kHz upregulate anti-senescence pathways in human dermal fibroblasts.
    Article Snippet: .. Hyaluronic acid and fibronectin production were determined using the Quantikine ELISA Hyaluronan immunoassay (Cat no: DHYAL0, R&D systems) and the Quantikine ELISA Human Fibronectin immunoassay (Cat no: DFBN10, R&D systems). ..



    Similar Products

    quantikine elisa human fibronectin immunoassay  (R&D Systems)
    94
    R&D Systems quantikine elisa human fibronectin immunoassay
    Quantikine Elisa Human Fibronectin Immunoassay, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/quantikine+elisa+human+fibronectin+immunoassay/Human+Fibronectin+Quantikine+ELISA+Kit/pm41365401-320-6-12
    Average 94 stars, based on 1 article reviews
    quantikine elisa human fibronectin immunoassay - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    fibronectin immunoassay  (R&D Systems)
    94
    R&D Systems fibronectin immunoassay
    Figure 2. Biofunctions of nsEVs and eEVs in vitro. (a) Proliferation of HDFs treated with nsEVs and eEVs, respectively. Cells were continuously photographed at 0, 24, and 48 h timepoints. The cell number was counted by ImageJ. The nsEVs- and eEVs-treated HDFs showed increased proliferation at 24 and 48 h timepoints (p < 0.01). (b) BrdU-positive percentage confirmed increased proliferation of HDFs treated with nsEVs or eEVs (p < 0.01). (c) Wound-healing assay of nsEVs- and eEVs-treated HDFs (p < 0.05). Red lines indicate wound boundary. (d) In transwell migration assay, cells at the bottom of the membrane were recorded and counted with ImageJ. Compared to the control group, more nsEVs- and eEVs-treated HDFs can translocate through the pores (p < 0.01). (e) Measurement of matrix proteins, including collagen, fibronectin, and elastin in HDFs treated with nsEVs or eEVs (p < 0.05). (f) Matrix metalloproteinases (MMP)-1 and MMP-3 activities at the mRNA level in HDFs treated with nsEVs and eEVs, respectively (p < 0.05). (g) MMP-1 and MMP-3 activities at the protein level in HDFs treated with nsEVs and eEVs, respectively (p < 0.05).
    Fibronectin Immunoassay, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/quantikine+elisa+human+fibronectin+immunoassay/Human+Fibronectin+Quantikine+ELISA+Kit/pm31909348-194-29-32
    Average 94 stars, based on 1 article reviews
    fibronectin immunoassay - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Figure 2. Biofunctions of nsEVs and eEVs in vitro. (a) Proliferation of HDFs treated with nsEVs and eEVs, respectively. Cells were continuously photographed at 0, 24, and 48 h timepoints. The cell number was counted by ImageJ. The nsEVs- and eEVs-treated HDFs showed increased proliferation at 24 and 48 h timepoints (p < 0.01). (b) BrdU-positive percentage confirmed increased proliferation of HDFs treated with nsEVs or eEVs (p < 0.01). (c) Wound-healing assay of nsEVs- and eEVs-treated HDFs (p < 0.05). Red lines indicate wound boundary. (d) In transwell migration assay, cells at the bottom of the membrane were recorded and counted with ImageJ. Compared to the control group, more nsEVs- and eEVs-treated HDFs can translocate through the pores (p < 0.01). (e) Measurement of matrix proteins, including collagen, fibronectin, and elastin in HDFs treated with nsEVs or eEVs (p < 0.05). (f) Matrix metalloproteinases (MMP)-1 and MMP-3 activities at the mRNA level in HDFs treated with nsEVs and eEVs, respectively (p < 0.05). (g) MMP-1 and MMP-3 activities at the protein level in HDFs treated with nsEVs and eEVs, respectively (p < 0.05).

    Journal: ACS omega

    Article Title: Preparation of Engineered Extracellular Vesicles Derived from Human Umbilical Cord Mesenchymal Stem Cells with Ultrasonication for Skin Rejuvenation.

    doi: 10.1021/acsomega.9b03561

    Figure Lengend Snippet: Figure 2. Biofunctions of nsEVs and eEVs in vitro. (a) Proliferation of HDFs treated with nsEVs and eEVs, respectively. Cells were continuously photographed at 0, 24, and 48 h timepoints. The cell number was counted by ImageJ. The nsEVs- and eEVs-treated HDFs showed increased proliferation at 24 and 48 h timepoints (p < 0.01). (b) BrdU-positive percentage confirmed increased proliferation of HDFs treated with nsEVs or eEVs (p < 0.01). (c) Wound-healing assay of nsEVs- and eEVs-treated HDFs (p < 0.05). Red lines indicate wound boundary. (d) In transwell migration assay, cells at the bottom of the membrane were recorded and counted with ImageJ. Compared to the control group, more nsEVs- and eEVs-treated HDFs can translocate through the pores (p < 0.01). (e) Measurement of matrix proteins, including collagen, fibronectin, and elastin in HDFs treated with nsEVs or eEVs (p < 0.05). (f) Matrix metalloproteinases (MMP)-1 and MMP-3 activities at the mRNA level in HDFs treated with nsEVs and eEVs, respectively (p < 0.05). (g) MMP-1 and MMP-3 activities at the protein level in HDFs treated with nsEVs and eEVs, respectively (p < 0.05).

    Article Snippet: In each group, 3 × 105 HDFs were harvested and the soluble collagen and fibronectin in the supernatant and elastin were measured with the collagen assay kit (ab242291, Abcam), fibronectin immunoassay (DFBN10, R&D Systems), and the elastin ELISA kit (ab239433, Abcam), respectively.

    Techniques: In Vitro, Wound Healing Assay, Transwell Migration Assay, Membrane, Control